PLENDIL
Pronunciation: fe-LOE-di-peen


What it isDihydropyridine L-type calcium-channel blocker; hypertension.
Why this oneIts extended-release-only formulation gives smooth pressure control but little practical advantage over amlodipine.
What limits itPeripheral edema and reflex tachycardia can limit use; grapefruit markedly raises exposure through intestinal CYP3A4 inhibition.
Animated chart of estimated U.S. prescriptions per year, Calcium-channel blockers (1981–2026). Felodipine enters in 1991 (estimated).
Principal riskPeripheral edema; grapefruit raises exposure severalfold
Legacy pregnancy categoryC
Defining liabilityHypotension and edema therapeutically; overdose can cause prolonged vasodilatory or cardiogenic shock.
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Hypertension | Adults | 5 mg QD | 2.5–10 mg QD | 10 mg QD |
Titration Adjust dose at intervals of not less than 2 weeks
Renal Usually no dosage modification required
Hepatic May have elevated plasma concentrations and respond to lower doses — monitor BP closely and start low
Available strengths
Pregnancy Undefined
Lactation Undefined
Generic entry2004
Open Felodipine in the interactive console ↗

Open Felodipine in the interactive console ↗